Article
Chicago-Two alpha-blockers appear to have modest efficacy in treatingchronic prostatitis/chronic pelvic pain syndrome, according to separatestudies presented here.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
Pearls & Perspectives: Advancing sexual health in urology, with Rachel Rubin, MD, at AUA 2025
Vaginal prolapse repair and sling surgery significantly reduce UUI
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
FDA grants marketing authorization to at-home diagnostic test for STIs
Expert discusses unique mechanism of action of UTI treatment gepotidacin
Meeting with FDA paves way for phase 3 trial of PT-112 in mCRPC
Study shows value of precision-based approaches in prostate cancer
Urologic surgeons successfully complete world’s first bladder transplant
Patient selection for cytoreductive nephrectomy in 2025